We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03833167
Brief Title: Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

First Submitted : February 4, 2019
First Submitted that Met QC Criteria : February 4, 2019
First Posted : February 6, 2019

Last Update Submitted that Met QC Criteria : November 24, 2022
Last Update Posted : November 28, 2022